On September 8, 2022 PURMX Therapeutics (headquartered in Hiroshima, Japan; Hidetoshi Tahara, President & CEO; hereinafter referred to as "the Company") reported the company has received the "Special Award for Academic Startups" at the "Award for Academic Startups" hosted by the National Science and Technology Agency (JST) for the fiscal year 2022 (Press release, PURMX Therapeutics, SEP 8, 2022, View Source [SID1234653370]). (headquartered in Hiroshima City, Japan; President: Hidetoshi Tahara; hereinafter referred to as "the Company") has received the "Special Award for Academic Startups" at the "Award for Academic Startups" organized by the Japan Science and Technology Agency (JST) for fiscal year 2022.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!